Aethlon Medical (NasdaqCM:AEMD) Q2 2026 Earnings Call November 12, 2025 04:30 PM ET Speaker2Today's event is being recorded. I would now like to turn the conference over to Jim Frakes, CEO and CFO. Please go ahead.Speaker5Thank you, Operator. Good afternoon, everyone. Welcome to Aethlon Medical's fiscal second quarter 2026 earnings conference call. My name is Jim Frakes, and I'm the Chief Executive Officer and Chief Financial Officer of Aethlon Medical. At 4:15 P.M. Eastern Time today, Aethlon Medical relea ...

INNOVATE (NYSE:VATE) Q3 2025 Earnings Call November 12, 2025 04:30 PM ET Speaker1Good afternoon and welcome to the INNOVATE Corp third quarter 2025 earnings conference call. All participants will be in a listen-only mode. After the prepared remarks and presentation, there will be a question-and-answer session. Please note this event is being recorded. I would now like to turn the conference call over to Neil Sikka with Investor Relations. Please go ahead.Speaker0Good afternoon. Thank you for being with us t ...

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors in Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”) securities that a securities class action has been filed on behalf of all investors who purchased shares between August 6, 2024 and August 4, 2025 (the “Class Period”). Investors have until January 5, 2026 to seek appointment as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Allegations The complaint filed allege ...

WHEAT RIDGE, CO / ACCESS Newswire / November 12, 2025 / Lifeloc Technologies, Inc. (OTC:LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended September 30, 2025. Third Quarter Financial Highlights Lifeloc posted quarterly net revenue of $2.257 million in the third quarter of 2025, resulting in a quarterly net loss of $(263) thousand, or $(0.10) per diluted share. ...

法律调查与投资者诉讼 - 律师事务所Faruqi & Faruqi正在对Inspire Medical Systems Inc进行调查 并提醒投资者关于2026年1月5日的首席原告申请截止日期 [3] - 诉讼指控公司及其高管在2024年8月6日至2025年8月4日期间 就Inspire V设备的实际市场需求和成功上市准备情况做出虚假和/或误导性陈述 违反了联邦证券法 [2][6] Inspire V设备上市受挫 - 2025年8月4日 公司宣布Inspire V设备上市遭遇重大挫折 因许多治疗中心尚未完成使用该产品所需的培训、合同签订和入职流程 导致推广时间远超预期 [7] - 公司披露了计费和报销方面的挑战 尽管医疗保险已批准了Inspire V的CPT代码 但处理索赔所需的软件更新直到2025年7月1日才生效 导致植入中心在此日期前无法对手术进行计费 转而继续使用旧的Inspire IV系统 [7] 财务影响与市场反应 - 除了物流和报销问题 Inspire V的发布还面临需求疲软和库存过剩的问题 这些问题迫使公司将2025年收益指引大幅下调超过80% [8] - 上述消息披露后 公司股价在2025年8月5日单日下跌超过32% 从2025年8月4日的每股12995美元跌至每股8791美元 导致市值蒸发约12亿美元 [8]

KORU Medical Systems Q3 2025 Earnings Call November 12, 2025 1 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. All statements that are not historical fact are forward-looking statements. Forward-looking statements discuss the Company's current expectations and projections relating to its financial position, results of operations, plans, objectives, future performa ...

集体诉讼案件基本信息 - Robbins Geller Rudman & Dowd LLP宣布，在2024年8月6日至2025年8月4日期间购入Inspire Medical Systems, Inc (NYSE: INSP)普通股的购买者或收购方，可在2026年1月5日前寻求被任命为该集体诉讼的首席原告 [1] - 案件名称为City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., 案号为No. 25-cv-04247 (D. Minn) [1] - 该诉讼指控Inspire Medical及其部分高管违反了《1934年证券交易法》 [1] 公司业务与涉诉产品 - Inspire Medical开发并制造了一种用于治疗阻塞性睡眠呼吸暂停的植入式医疗设备，名为“Inspire” [2] - 该设备的最新迭代产品Inspire V采用植入式传感器和神经刺激器，据称旨在改善睡眠期间的呼吸 [2] 诉讼指控内容 - 诉讼指控被告在整个集体诉讼期间作出虚假和/或误导性陈述，和/或未能披露以下信息 [3] - Inspire V的发布是一场灾难，因为对其需求疲软，供应商拥有大量过剩库存且不愿转向新的治疗方案 [3] - 尽管被告向投资者保证公司已采取所有必要措施以确保成功发布，但公司未能完成发布所需的基本准备工作 [3] - 2025年8月4日，公司披露Inspire V的发布面临“延长时间框架”，原因包括许多中心未完成购买和植入前所需的培训、合同和入职标准 [4] - 尽管Inspire V的CPT代码已获批准用于Medicare患者，但索赔提交和处理的软件更新直到7月1日才生效，这意味着植入中心在7月1日前无法对这些手术进行收费 [4] - 投资者首次得知，由于库存过剩导致需求不佳，Inspire V的推广受阻 [4] 披露后市场与财务影响 - 因此，Inspire Medical将其2025年盈利指引下调了超过80% [4] - 在该消息公布后，Inspire Medical普通股价格下跌超过32% [4]

NEWTOWN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana (SOL), today announced that the Company will release its third quarter operating results on Tuesday, November 18, 2025, after market close. Management will host a conference call to discuss the results and provide an expanded business update as follows: Date:Tuesday, Nove ...

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences. Jefferies London Healthcare Conference 2025 Tuesday, November 18, 2025Waldorf Hilton, LondonDorian LeBlanc, CFO, will present at 8:00 AM GMT Wolfe Research 7th Annual Healthcare Conference Wednesday, November 19, 2025Wolfe NYC Offices, New York, NYDavid Roberts, President, will present at 10:40 AM ET Piper Sandler 37th Annual Heal ...

Revenue increases 8% Year-Over-Year and 9% Year-To-DateLOUISVILLE, Ky., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMKD) (the Company), a provider of personal safety and emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, today announced financial and operational results for the third quarter ended September 30, 2025. Summary Highlights: Revenues increased 8% to $2.9 million in the third quarter of 2025, compared with the co ...